Success with Avelox®
Community Acquired Pneumonia
Acute Exacerbations of Chronic Bronchitis
Acute Bacterial Sinusitis
Click on link to view key efficacy trial data for Avelox®
read more
Introduction to Dr Microbe
European Physician Continuing Medical Education - earn 3 eCME credits by completing this programme read more
Your Opinion Counts
In your practice, what percentage of patients requiring treatment for community acquired pneumonia (CAP) have an underlying condition (e.g. pulmonary obstruction, lung disease, or immunodeficiency)?
